To validate the clinical relevance of our findings, we analyzed the relationship between glutaminase and glutamine transporter ASCT2 expression levels and outcome of ovarian cancer patients using the PrognoScan database [28]. This evidence concerns the gene GLS and ovarian carcinoma.